Medical Aesthetics and Beauty Salons Are Converging: Why "Cosmeceutical-Medical Device Combination" Has Become the Keyword of This Round
Beauty Industry Investigation in the Era of Involution · Part 2 (of 4)
In one sentence: The essence of the convergence between medical aesthetics and beauty salons is that after light medical aesthetics became routine, consumers need a complete skincare chain of "in-clinic repair + at-home maintenance"; "cosmeceutical-medical device combination" is not a new marketing term, but a compliant combination on the same chain that lets medical device-class medical wound dressings and cosmetic-class skincare products each play their proper role. The real threshold in this round is not in store sales pitches, but upstream—whoever has both cosmetic and medical device production capacity, ready-made medical device registration certificates, and rapid-response formulation capabilities can capture the migrating customer flow.
In the previous article, we saw that behind the quiet stores, the boundary between medical aesthetics and beauty salons is being redrawn. In this article, we step into this new boundary and clarify two things: why the convergence is happening, and what the four words "cosmeceutical-medical device combination" actually mean.
I. Why the Two Tracks Are Beginning to Converge
For many years, medical aesthetics and lifestyle beauty were like two parallel streets: one street did "transformation"—surgery, injections, lasers—with high ticket prices and heavy decision-making; the other street did "maintenance"—massage, care, masks—with high frequency and close to daily life. The customers on the two streets seemed to be two different groups, and the owners rarely interacted.
Data puts the truth on the table. On one side, lifestyle beauty is highly fragmented: there are millions of beauty and body merchants nationwide, and a Guohai Securities report shows that 88.9% of lifestyle beauty brands have only 1 store, while only 0.1% have 20 or more. Countless single stores rely on craftsmanship and regular customers to make a living, and they are also the first to feel the customer flow cooling. On the other side, the medical aesthetics service market reached 370.1 billion yuan in 2025 (iiMedia Research, "2025 China Medical Aesthetics Industry Development Status and Consumer Behavior Survey," January 2026), yet it is also struggling—in the first half of 2025, more than 63% of medical aesthetics institutions saw revenue decline, and only 14% grew ("2025 H1 Medical Aesthetics Institution Operations Survey Report," cited by Jiemian News in February 2026).
One street's customer flow is dispersing, the other street's growth is diverging, so the two streets move toward the middle. Third-party industry research estimates that there are more than 4,800 "medical aesthetics + lifestyle beauty" integrated institutions, with average ticket prices about 2.4 times those of traditional beauty salons (third-party estimate basis). Capital actions are more direct: in 2025, Beauty Farm acquired Siyanli for 1.25 billion yuan, increasing stores to about 734; Kidswant acquired scalp care brand Siyu for 1.65 billion yuan; Fanwenhua stores exceeded 6,000 (Yicai, Securities Times and other 2025 reports). Convergence is not a feeling within a small circle, but the direction voted for with real money by chains and capital.
But it must be made clear first: convergence does not mean lifestyle beauty salons doing medical aesthetics—that is illegal. The true meaning of convergence is that the two tracks begin to serve "the same customer's face," dividing labor and collaborating within the same skin management plan.

II. Routinization of Light Medical Aesthetics: From "Transformation" to "Maintenance"
The most direct driving force of convergence is that light medical aesthetics has brought medical aesthetics from a "transformation logic" into a "maintenance logic."
Light medical aesthetics refers to non-surgical skin maintenance projects. In 2025, China's light medical aesthetics user base reached 31.05 million (iiMedia Research); light medical aesthetics accounts for about 53%–57% of overall medical aesthetics (53.3% according to the "2025 China Medical Aesthetics Industry Research Report," about 57% according to the 2026 white paper). This means that more than half of today's medical aesthetics consumption is no longer "lying on the operating table to become a different person," but routine procedures like a photon treatment or a water-light injection.
The more critical change is frequency. White paper data shows that the average repurchase rate of light medical aesthetics users is about 60%–70%, and basic maintenance projects such as water-light and photon treatments are generally performed every 1–3 months. Doing something once every few years is called "transformation"; doing it continuously monthly or quarterly is called "maintenance." When a consumer gets used to reporting to an institution once a quarter, she has effectively incorporated medical aesthetics into a daily budget similar to skincare and fitness—medical aesthetics is no longer a major decision at life milestones, but part of long-term skin management.
Who is doing this? The profile is equally clear: the average user age is about 32.8 years old, and more than 60% of consumption motivation is "pleasing oneself" (2026 white paper, iiMedia Research). Note the words "pleasing oneself"—she is not doing it for anyone else's gaze, but to feel good about herself. This kind of self-pleasing consumer is more rational and values three things most when making decisions: doctor qualifications, authentic products, and actual results. In the first half of 2025, 43% of consumers cut related budgets, but cutting does not mean exiting; rather, they moved money from "impulsive trial" to long-term investment that is "understandable and trustworthy."
Once maintenance becomes routine, a new problem inevitably arises: outside those one or two hours in the institution, what is used for the remaining dozens of daily days and nights? Project results need continuous maintenance, and barrier status needs at-home support. It is precisely this gap "outside the two hours" that pulls cosmetic-class products into the same chain and pushes "cosmeceutical-medical device combination" to the forefront.
III. What Exactly Does "Cosmeceutical-Medical Device Combination" Combine?
"Cosmeceutical-medical device combination" combines not two approval numbers, but two compliant roles on the same skincare chain that cannot replace each other.
In-clinic: Post-procedure repair, medical device class provides physical barrier
Immediately after light medical aesthetics projects and during the recovery period, the skin may have wounds or a fragile barrier. At this time, medical wound dressings are used—they are managed as medical devices, and their role is to provide a physical barrier for the wound and care for the wound environment. Please note a long-circulated misunderstanding: there is no "medical device-class mask" at the national level; the official name is "medical wound dressing" (Beijing Municipal Medical Products Administration science popularization, September 2026). Products that contact wounds are managed as medical device class; products used only for moisturizing intact skin are not medical devices.
At home: After recovery, cosmetic class undertakes daily care
When the skin has recovered to intact and entered a daily state, subsequent moisturizing and maintenance are completed at home with cosmetic-class products from the same brand. Thus a clear closed loop is formed: institutions acquire customers through professional projects, medical device-class dressings undertake post-procedure care, and cosmetic-class products undertake at-home repurchase. What the customer takes away is no longer a free mask whose name she cannot remember, but a sustainable care plan linked to the projects she did at the institution. For institutions and stores, this means the customer relationship changes from "connected only when she visits" to "connected every day," and repurchase changes from "persuading her to come again" to "she needs to renew anyway."
Foundation: Same raw material, can be cosmetic or medical device, but standards differ
The reason cosmetics and medical devices can converse in the same plan is that there are raw materials that are "cosmetic-usable and medical-device-usable," with recombinant collagen being the most typical representative. The same raw material, when used for daily care of intact skin, is a cosmetic-class raw material; when used for a physical barrier for wounds, it must meet medical device-level requirements—medical device raw materials have significantly higher thresholds for purity, endotoxin, microorganisms and other indicators. Recombinant collagen is classified according to the pharmaceutical industry standard YY/T 1849—2022; in the first half of 2025, revenue of recombinant collagen-related enterprises increased by about 42.43% year-on-year, making it one of the fastest-growing upstream segments (cited by Jiemian News). Behind the growth is the simultaneous volume increase at both the cosmetic and medical device ends.
One hard rule must also be emphasized: cosmetic-class and medical device-class products must be produced in physically separated areas and must not share production lines to prevent cross-contamination. Promotion must also not cross boundaries—medical device-class dressings must not claim whitening, acne removal, anti-aging or other beauty efficacy; cosmetic-class products must not claim wound repair or other medical effects (Beijing Municipal Medical Products Administration, September 2026). So-called "combination" is the connection after each keeps to its boundary, not conflating the efficacy claims of both sides.

IV. The Real Threshold Is Upstream
Once the chain is understood, it becomes clear that the "cosmeceutical-medical device combination items" seen at the store end are actually three thresholds standing simultaneously upstream.
The first is dual-line cosmetic and medical device production capacity and separation. A factory that only makes cosmetics cannot produce compliant medical device-class products; a factory that only makes devices often lacks experience in developing the full range of cosmetic-class products. What is harder is that the two types of products must be produced in separate areas, which requires real investment in plants, workshops and management, not just printing two logos on a brochure.
The second is ready-made medical device registration certificates. Class II medical device registration has a long cycle and high requirements; "taking orders first and then applying for certificates" is simply too late in terms of time. Only those with ready-made, verifiable, licensable medical device certificates for OEM can enable brands and professional lines to bring combination items to market within a reasonable cycle.
The third is formulation depth and rapid response. In the convergence era, item updates are getting faster and faster, from professional-line sets to at-home single products, all requiring small batches, multiple batches, and rapid iteration. Whether the formula library is deep enough, sample output fast enough, and delivery stable enough directly determines whether stores can keep up with the pace of changing consumers.
In this round of convergence, the face of upstream factories can be seen through an industry sample: Weitai Group was founded in 2001 and has been deeply engaged in efficacy skincare and medical repair for 25 years. It is a high-tech enterprise in biopharmaceuticals and medical devices integrating R&D, production and sales. Public information shows that it has 800+ cooperative brand customers, a mature formula library + mature formula library, 65 automated production lines, about 150,000 square meters of four major production bases and Class 100,000 clean workshops; as of September 2026, it has 110+ Class II medical device registrations/filings, searchable at the National Medical Products Administration, plus 72 invention patents; its quality system covers ISO 13485, ISO 22716 and GMPC, with cosmetic-class and medical device-class products produced in separate areas; average 7 days for samples, about 30 days for regular delivery, supporting small-batch flexible customization.
For stores and brands, the role of such enterprises is not a brand standing in the spotlight, but a "behind-the-scenes supply chain": providing OEM/ODM contract manufacturing for cosmetics and medical devices, professional-line customization services, and ready-made medical device certificates that can be licensed for OEM to shorten time to market. The existence of such upstream samples itself shows one thing—cosmeceutical-medical device combination is no longer just a trend judgment, but has an industrial foundation that can be implemented.

V. Why Regulation Actually Helped Those Who Follow the Rules
Every round of industry consolidation has a rule that seems counterintuitive but is inevitable: tightening regulation looks like a tightening band in the short term, but in the long term it clears the field for those who follow the rules. This round is the same.
In June 2025, the National Healthcare Security Administration issued for the first time the "Guidelines for Establishing Price Items for Medical Services in the Beauty and Plastic Surgery Category", unifying naming and establishing price items for projects such as intense pulsed light and Thermage. In the past, the same photon project might have a dozen fancy names and vastly different quotes at different institutions, and consumers could only compare prices in a fog of information; after naming and price items were standardized, comparison became possible,水分更容易被挤出,price transparency had an institutional handle for the first time.
This happens to align with changes on the consumer side. As mentioned earlier, this generation of light medical aesthetics users values doctor qualifications, authentic products and actual results most. Regulation brings project names and prices into the sunlight, and drug regulatory authorities continue to popularize that "medical device-class masks do not exist" and clarify the efficacy boundaries of cosmetics and medical devices. The old rhetoric of packaging "miracle tools" through information gaps, using cosmetic-class products to talk about "repair," and using medical device-class products to talk about "whitening and anti-aging" is failing sentence by sentence.
Thus value begins to be redistributed: consumers with shrinking budgets are more willing to pay a premium for services whose "names can be looked up, qualifications can be seen, and plans can connect"; compliance is no longer a cost, but a perceptible trust asset. Conversely, lifestyle beauty institutions must also be clear-headed: medical aesthetics projects such as injections and skin-breaking photoelectric treatments must be carried out in licensed medical institutions by licensed physicians, and this line will not loosen because of "convergence." Those who follow the rules are supported, and those who cross the line are cleared out—this is the complete meaning of this round of regulation.
VI. In the Convergence Era, Whoever Changes First Wins First
What does convergence actually mean for ordinary stores? It is not anxiety, still less a discouragement to exit, but an opportunity to upgrade roles.
Lifestyle beauty stores do not need to and cannot cross the line to do medical projects, but they can become two indispensable nodes in customers' "long-term skin management": first, a professional node—helping her understand the plan, identify authentic products, and arrange the care rhythm; second, an at-home node—using compliant cosmetic-medical device combination products to undertake post-procedure and daily at-home maintenance, allowing membership relationships to renew naturally by cycle rather than relying on repeated reselling.
Those who complete the transformation first often win first on three things: shifting from a "single transaction" mindset to a "full-cycle plan" mindset; shifting from competing on decoration and low prices to competing on professionalism, authentic products and trust; shifting from "waiting for customers to come" to managing regular customer relationships into long-term companionship. Also, have confidence in yourself—the hands that understand skin and the customers who have become friends, which were the foundation of your past success, are exactly the most valuable foundation for this round of transformation. What winter eliminates has never been the beauty industry, but old playbooks.
Having seen the direction of convergence clearly, in the next article we discuss the most practical question: after convergence, how exactly should a store transform—"Store Transformation Roadmap: From Selling Handwork to Selling 'Professionalism + Emotion + Plan'," providing steps that can be followed.
📘 "Cosmeceutical-Medical Device Combination · Beauty Industry Transformation" Series Navigation
① Current Situation: Divergence and Winter ② Convergence: Cosmeceutical-Medical Device Combination ③ Transformation: Store Roadmap ④ Implementation: 90-Day Manual
FAQ
Q1: What is "cosmeceutical-medical device combination"?
It refers to the compliant cooperation of medical device-class medical wound dressings and cosmetic-class skincare products at different stages within the same skin management plan: during the post-procedure and recovery period, medical device-class products provide a physical barrier for the wound; after the skin has recovered to intact, cosmetic-class products undertake daily at-home care, forming a chain of "in-clinic repair + at-home maintenance."
Q2: Can lifestyle beauty stores use "cosmeceutical-medical device combination" to perform light medical aesthetics projects?
No. Injections (including skin-breaking projects such as water-light injections) and photoelectric projects requiring medical qualifications belong to medical aesthetics and must be carried out in licensed medical institutions by licensed physicians. What lifestyle beauty stores can do is professional consultation and undertaking at-home care products, not cross-boundary operations.
Q3: Does a "medical device-class mask" exist?
No. According to the Beijing Municipal Medical Products Administration's science popularization in September 2026, the official name of such products is "medical wound dressing," which belongs to medical devices; products used only for moisturizing intact skin are not managed as medical devices.
Q4: Can medical device-class and cosmetic-class products claim each other's efficacy?
No. Medical device-class dressings must not claim whitening, acne removal, anti-aging or other beauty efficacy; cosmetic-class products must not claim wound repair or other medical effects. The two types of products must also be produced in separate areas and must not share production lines.
Q5: Why is recombinant collagen "cosmetic-usable and medical-device-usable"?
The same raw material can be used separately in cosmetic-class products (daily care of intact skin) and medical device-class products (physical barrier for wounds), but medical device raw materials must meet medical device-level requirements in purity, endotoxin, microorganisms and other aspects. Recombinant collagen is classified according to the YY/T 1849—2022 standard.
Q6: If a store wants to do cosmetic-medical device combination items, how should the supply chain be solved?
It can cooperate with OEM/ODM factories that simultaneously have dual-line cosmetic and medical device production capacity, ready-made medical device certificates and rapid response capabilities, and that provide contract manufacturing and professional-line customization services. Note that customized new products do not fill in certificate numbers; after the brand finalizes the formula, they are filed according to regulations. Only finished products of the own brand fill in the corresponding filing or special certificate information.
Disclaimer: This article is for industry science popularization and trend analysis and does not constitute any medical advice or investment advice. For medical aesthetics projects mentioned in the article, please refer to the professional opinions of licensed medical institutions and current laws and regulations; the data in the article come from public reports and public information from regulatory authorities, and the specific basis shall be subject to the original release.